SAN FRANCISCO, Dec. 13 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of the life sciences and healthcare services...
RESTON, Va., Nov. 26 /PRNewswire-FirstCall/ -- PRA International (NASDAQ:PRAI), a leading clinical research organization, today announced that Jeffrey B. Chambers has been named its senior vice...
RESTON, Va., Nov. 7 /PRNewswire-FirstCall/ -- PRA International (NASDAQ:PRAI), a leading global clinical research organization, today announced operating results for the third quarter ended...
PRA Oncology Expert to Speak RESTON, Va., Oct. 23 /PRNewswire-FirstCall/ -- PRA International (NASDAQ:PRAI) today announced that Dr. Ute Berger, the company's senior director of therapeutic...
RESTON, Va., Sept. 25 /PRNewswire-FirstCall/ -- PRA International (NASDAQ:PRAI) announced today that it plans to relocate its corporate headquarters from Reston, Va., to the Raleigh, N.C. area...
RESTON, Va., Sept. 5 /PRNewswire-FirstCall/ -- PRA International (NASDAQ:PRAI), a leading clinical research organization, today announced the appointment of Dr. Susan C. Stansfield as Executive...
Service Revenue Up 29%; Record Backlog Increases 35% RESTON, Va., July 25 /PRNewswire-FirstCall/ -- PRA International (NASDAQ:PRAI), a leading global clinical research organization, today...
PRA Stockholders to Receive $30.50 Per Share in Cash; Transaction Valued at $790 Million RESTON, Va., July 25 /PRNewswire-FirstCall/ -- PRA International (NASDAQ:PRAI), a leading global clinical...
RESTON, Va., July 16 /PRNewswire-FirstCall/ -- PRA International (NASDAQ:PRAI), a leading clinical research organization, will release second quarter 2007 earnings results and host an...
RESTON, Va., June 19 /PRNewswire-FirstCall/ -- PRA International (NASDAQ:PRAI), a leading clinical research organization, today announced that Terrance J. Bieker, PRA's Chief Executive Officer...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales